JP2007523624A5 - - Google Patents

Download PDF

Info

Publication number
JP2007523624A5
JP2007523624A5 JP2006522189A JP2006522189A JP2007523624A5 JP 2007523624 A5 JP2007523624 A5 JP 2007523624A5 JP 2006522189 A JP2006522189 A JP 2006522189A JP 2006522189 A JP2006522189 A JP 2006522189A JP 2007523624 A5 JP2007523624 A5 JP 2007523624A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006522189A
Other languages
Japanese (ja)
Other versions
JP5576010B2 (ja
JP2007523624A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2004/001449 external-priority patent/WO2005012526A1/en
Publication of JP2007523624A publication Critical patent/JP2007523624A/ja
Publication of JP2007523624A5 publication Critical patent/JP2007523624A5/ja
Application granted granted Critical
Publication of JP5576010B2 publication Critical patent/JP5576010B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006522189A 2003-08-04 2004-07-30 ラフォラ病遺伝子 Expired - Fee Related JP5576010B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49196803P 2003-08-04 2003-08-04
US60/491,968 2003-08-04
PCT/CA2004/001449 WO2005012526A1 (en) 2003-08-04 2004-07-30 Lafora's disease gene

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011261115A Division JP2012095651A (ja) 2003-08-04 2011-11-30 ラフォラ病遺伝子

Publications (3)

Publication Number Publication Date
JP2007523624A JP2007523624A (ja) 2007-08-23
JP2007523624A5 true JP2007523624A5 (https=) 2008-03-06
JP5576010B2 JP5576010B2 (ja) 2014-08-20

Family

ID=34115575

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006522189A Expired - Fee Related JP5576010B2 (ja) 2003-08-04 2004-07-30 ラフォラ病遺伝子
JP2011261115A Pending JP2012095651A (ja) 2003-08-04 2011-11-30 ラフォラ病遺伝子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011261115A Pending JP2012095651A (ja) 2003-08-04 2011-11-30 ラフォラ病遺伝子

Country Status (4)

Country Link
US (4) US7871768B2 (https=)
JP (2) JP5576010B2 (https=)
CA (1) CA2534382C (https=)
WO (1) WO2005012526A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825328B1 (en) 1998-07-20 2004-11-30 Stephen W. Scherer Lafora's disease gene
WO2005012526A1 (en) 2003-08-04 2005-02-10 The Hospital For Sick Children Lafora's disease gene
EP2812342B1 (en) 2012-02-08 2017-11-15 Ionis Pharmaceuticals, Inc. Modulation of rna by repeat targeting
US10202591B2 (en) 2014-06-13 2019-02-12 Valerion Therapeutics, Llc Methods and compositions for treatment of glycogen storage diseases and glycogen metabolism disorders
EP3471781A4 (en) 2016-06-17 2020-05-06 Ionis Pharmaceuticals, Inc. MODULATION OF GYS1 EXPRESSION
WO2025076463A1 (en) * 2023-10-06 2025-04-10 The Board Of Regents Of The University Of Texas System Gene therapy for lafora disease

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4401796A (en) 1981-04-30 1983-08-30 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4373071A (en) 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4598049A (en) 1983-08-31 1986-07-01 Systec Inc. General purpose gene synthesizer
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US4863195A (en) 1987-10-02 1989-09-05 Capozzola Carl A Identification tag
AU622426B2 (en) 1987-12-11 1992-04-09 Abbott Laboratories Assay using template-dependent nucleic acid probe reorganization
US5130238A (en) 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
GB9021679D0 (en) 1990-10-05 1990-11-21 Gorman Scott David Antibody preparation
US5843456A (en) 1991-03-07 1998-12-01 Virogenetics Corporation Alvac poxvirus-rabies compositions and combination compositions and uses
US5888780A (en) 1992-12-07 1999-03-30 Third Wave Technologies, Inc. Rapid detection and identification of nucleic acid variants
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
US6045996A (en) 1993-10-26 2000-04-04 Affymetrix, Inc. Hybridization assays on oligonucleotide arrays
EP0705842A2 (en) 1994-10-06 1996-04-10 Hoechst Aktiengesellschaft Regulated genes by stimulation of chondrocytes with 1L-1beta
WO2000005405A2 (en) 1998-07-20 2000-02-03 Scherer Stephen W Lafora's disease gene
US6825328B1 (en) 1998-07-20 2004-11-30 Stephen W. Scherer Lafora's disease gene
JP3638516B2 (ja) 2000-09-28 2005-04-13 株式会社日立製作所 核酸検出方法および核酸検出キット
US20030092019A1 (en) * 2001-01-09 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
US7371580B2 (en) 2001-08-24 2008-05-13 Agilent Technologies, Inc. Use of unstructured nucleic acids in assaying nucleic acid molecules
US20030059823A1 (en) 2001-09-21 2003-03-27 Juki Corporation Hybridization apparatus and method for detecting nucleic acid in sample using the same
WO2004038003A2 (en) * 2002-10-25 2004-05-06 Five Prime Therapeutics, Inc. Human polypeptides encoded by polynucleotides and methods of their use
ATE364641T1 (de) 2003-04-03 2007-07-15 Basell Polyolefine Gmbh Herstellung von hochmolekularen polyolefinen in gegenwart einer organischen übergangsmetallverbindung in einem gasphasen- wirbelschichtreaktor
WO2005012526A1 (en) 2003-08-04 2005-02-10 The Hospital For Sick Children Lafora's disease gene

Similar Documents

Publication Publication Date Title
BE2024C508I2 (https=)
BE2023C542I2 (https=)
BE2022C549I2 (https=)
BE2021C001I2 (https=)
BE2020C513I2 (https=)
BE2020C517I2 (https=)
BE2019C540I2 (https=)
BE2019C523I2 (https=)
BE2019C548I2 (https=)
BE2019C506I2 (https=)
BE2020C525I2 (https=)
BE2018C045I2 (https=)
BE2017C063I2 (https=)
BE2017C027I2 (https=)
BE2017C023I2 (https=)
BE2017C002I2 (https=)
BE2016C067I2 (https=)
BE2016C014I2 (https=)
BE2015C041I2 (https=)
BE2015C038I2 (https=)
BE2015C014I2 (https=)
BE2014C071I2 (https=)
BE2015C015I2 (https=)
BE2014C064I2 (https=)
BE2014C063I2 (https=)